Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Research & Development (2016 - 2018)

Armata Pharmaceuticals' Research & Development history spans 6 years, with the latest figure at $2.0 million for Q4 2018.

  • For Q4 2018, Research & Development rose 82.02% year-over-year to $2.0 million; the TTM value through Dec 2018 reached $6.8 million, up 136.65%, while the annual FY2024 figure was $34.4 million, 1.94% up from the prior year.
  • Research & Development for Q4 2018 was $2.0 million at Armata Pharmaceuticals, up from $361000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $3.0 million in Q2 2018 and bottomed at -$829000.0 in Q3 2017.
  • The 5-year median for Research & Development is $1.1 million (2017), against an average of $1.3 million.
  • The largest annual shift saw Research & Development crashed 2121.95% in 2017 before it surged 166.28% in 2018.
  • A 5-year view of Research & Development shows it stood at $1.1 million in 2014, then plummeted by 34.59% to $728000.0 in 2015, then skyrocketed by 231.87% to $2.4 million in 2016, then crashed by 54.88% to $1.1 million in 2017, then surged by 82.02% to $2.0 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Research & Development are $2.0 million (Q4 2018), $361000.0 (Q3 2018), and $3.0 million (Q2 2018).